Consensus Approach to a Treat-to-target Strategy in Juvenile Idiopathic Arthritis Care: Report From the 2020 PR-COIN Consensus Conference

¹T. El Tal, MD, B.M. Feldman, MD, PhD, R.M. Laxer, MD, The Hospital for Sick Children, and University of Toronto, Toronto, Ontario, Canada;
²M.E. Ryan, DO, D. Bullock, MD, University of Minnesota, Minneapolis, Minnesota, USA;
³C.A. Bingham, MD, Penn State Children’s Hospital, Hershey, Pennsylvania, USA;
⁴J.M. Burnham, MD, Children’s Hospital of Philadelphia, Philadelphia, Pennsylvania, USA;
⁵M. Batthish, MD, McMaster University, Hamilton, Ontario, Canada;
⁶M. Gilbert, MD, Medical University of South Carolina, Charleston, South Carolina, USA;
⁷M. Gillispie-Taylor, MD, C. Yildirim Toruner, MD, Texas Children’s Hospital Baylor College of Medicine, Houston, Texas, USA;
⁸B. Gottlieb, MD, Cohen Children’s Medical Center, Lake Success, New York, USA;
⁹J.G. Harris, MD, Children’s Mercy Kansas City, Kansas City, Kansas, USA;
¹⁰M. Hazen, MD, Boston Children’s Hospital, Boston, Massachusetts, USA;
¹¹T.C. Lee, MD, Stanford Children’s Health, Palo Alto, California, USA;
¹²D. Lovell, MD, J. Taylor, CNP, Cincinnati Children’s Hospital Medical Center, Cincinnati, Ohio, USA;
¹³M. Mannion, MD, University of Alabama at Birmingham, Birmingham, Alabama, USA;
¹⁴L. Noonan, MD, Levine Children’s Hospital/Carolinas Healthcare System, Charlotte, North Carolina, USA;
¹⁵E. Oberle, MD, Nationwide Children’s Hospital, Columbus, Ohio, USA;
¹⁶J.E. Weiss, MD, Hackensack University Medical Center, Hackensack, Hackensack, New Jersey, USA;
¹⁷E.M. Morgan, MD, MSCE, University of Washington, and Seattle Children’s Hospital, Seattle, Washington, USA.

Address correspondence to Dr. E.M. Morgan, Seattle Children’s Hospital, Division of Rheumatology, 4800 Sand Point Way NE, Seattle, WA 98105, USA. Email: Esi.Morgan@seattlechildrens.org.